Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer, April 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 384 articles:
HTML format


 

Single Articles

  1. LI L, Zhang J, Zhe X, Tang M, et al
    A meta-analysis of MRI-based radiomic features for predicting lymph node metastasis in patients with cervical cancer.
    Eur J Radiol. 2022;151:110243.
    PubMed    
    Abstract available

  2. KIM N, Park W, Cho WK, Cho YS, et al
    Clinical outcomes after positron emission tomography/computed tomography-based image-guided brachytherapy for cervical cancer.
    Asia Pac J Clin Oncol. 2022 Apr 2. doi: 10.1111/ajco.13758.
    PubMed    
    Abstract available

  3. ANUMOLU N, Lechleitner K, Patel N, Jankowksi C, et al
    Professional views on priorities for cervical cancer policy in Uganda: a qualitative study.
    Lancet Glob Health. 2022;10 Suppl 1:S16.
    PubMed    
    Abstract available

  4. BEYER KMM, Kasasa S, Anguzu R, Nambooze S, et al
    Parish level social factors predict population-based cervical cancer incidence in Kampala, Uganda, 2008-15: an ecological study.
    Lancet Glob Health. 2022;10 Suppl 1:S12.
    PubMed    
    Abstract available

  5. FANG MH, Wang TY, Lee J, Jan YT, et al
    Essential roles of surgical and pathological evaluations in the management of foreign bodies or inflammatory granulomas mimicking cervical cancer recurrence: A report of two cases.
    Taiwan J Obstet Gynecol. 2022;61:391-394.
    PubMed    
    Abstract available

  6. CHO WK, Park W, Kim H, Kim YJ, et al
    Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy?
    Taiwan J Obstet Gynecol. 2022;61:329-332.
    PubMed    
    Abstract available

  7. GONG YF, Zhang Y, Li LY, Han W, et al
    Downregulation of miR-599 predicts poor outcome in cervical cancer patients and promotes the progression of cervical cancer.
    Taiwan J Obstet Gynecol. 2022;61:249-254.
    PubMed    
    Abstract available

  8. WALSH CS, Leath CA 3rd, Mayadev J, Randall LM, et al
    Cervical cancer - times... they are a changing: A report from the Society of Gynecologic Oncology journal club.
    Gynecol Oncol Rep. 2022;40:100949.
    PubMed    
    Abstract available

  9. CONTRERAS-ROMERO C, Perez-Yepez EA, Martinez-Gutierrez AD, Campos-Parra A, et al
    Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer.
    Front Oncol. 2022;12:773438.
    PubMed    
    Abstract available

  10. HOU X, Shen G, Zhou L, Li Y, et al
    Artificial Intelligence in Cervical Cancer Screening and Diagnosis.
    Front Oncol. 2022;12:851367.
    PubMed    
    Abstract available

  11. NYAMBE A, Kampen JK, Van Hal G
    Does Intervening in the Level of Knowledge About Cervical Cancer Increase Screening and Vaccination in Zambia?
    J Cancer Educ. 2022 Apr 1. pii: 10.1007/s13187-022-02159.
    PubMed    
    Abstract available

  12. PHILIPPE VT
    Indocyanine green guidance for combined robotic pelvic and para-aortic sentinel node mapping in cervical cancer.
    Surg Oncol. 2022;41:101745.
    PubMed    
    Abstract available

  13. HU C, Liu T, Xu Y, Han C, et al
    [METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m(6)A Myc expression].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022;38:131-137.
    PubMed    
    Abstract available

  14. ABDALLA E, Habtemariam T, Fall S, Troy R, et al
    A Comparative Study of Health Disparities in Cervical Cancer Mortality Rates Through Time Between Black and Caucasian Women in Alabama and the US.
    Int J Stud Nurs. 2021;6:9-23.
    PubMed    
    Abstract available

  15. ZHANG Y, Di Q, Chen J, Chang M, et al
    Circ_0000263 facilitates the proliferation and inhibits the apoptosis of cervical cancer depending on the regulation of miR-1179/ABL2 axis.
    Reprod Sci. 2022 Mar 30. pii: 10.1007/s43032-022-00920.
    PubMed    
    Abstract available

  16. JIN J, Zhu H, Teng Y, Ai Y, et al
    The Accuracy and Radiomics Feature Effects of Multiple U-net-Based Automatic Segmentation Models for Transvaginal Ultrasound Images of Cervical Cancer.
    J Digit Imaging. 2022 Mar 30. pii: 10.1007/s10278-022-00620.
    PubMed    
    Abstract available

  17. FEDERICO A, Anchora LP, Gallotta V, Fanfani F, et al
    Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study.
    Ann Surg Oncol. 2022 Mar 30. pii: 10.1245/s10434-022-11583.
    PubMed    
    Abstract available

  18. SMITH MA, Sherrah M, Sultana F, Castle PE, et al
    National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
    BMJ. 2022;376:e068582.
    PubMed    
    Abstract available

  19. MATTERN J, Letendre I, Sibiude J, Penager C, et al
    Diagnosis of advanced cervical cancer, missed opportunities?
    BMC Womens Health. 2022;22:97.
    PubMed    
    Abstract available


  20. Retraction of: HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells by Chi et al. (doi: 10.1089/hum.2017.256).
    Hum Gene Ther. 2022 Mar 28. doi: 10.1089/hum.2017.
    PubMed    


  21. ZHANG W, Zhai Q, Li M, Huang S, et al
    Anti-Cancer Effects of Disulfiram in Cervical Cancer Cell Lines Are Mediated by Both Autophagy and Apoptosis.
    Bull Exp Biol Med. 2022 Mar 30. pii: 10.1007/s10517-022-05447.
    PubMed    
    Abstract available

  22. ZHANG L, Guo C, Ji T, Chen X, et al
    Retraction Note to: SOX2 Regulates lncRNA CCAT1/MicroRNA-185-3p/FOXP3 Axis to Affect the Proliferation and Self-Renewal of Cervical Cancer Stem Cells.
    Nanoscale Res Lett. 2022;17:39.
    PubMed    


  23. SINGINI MG, Singh E, Bradshaw D, Chen WC, et al
    HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women.
    Infect Agent Cancer. 2022;17:14.
    PubMed    
    Abstract available

  24. YE Y, Chen M, Chen X, Xiao J, et al
    Clinical Significance and Prognostic Value of Lactate Dehydrogenase Expression in Cervical Cancer.
    Genet Test Mol Biomarkers. 2022;26:107-117.
    PubMed    
    Abstract available

  25. MAHAS R, Neale AV
    Cervical cancer prevention in the United States and United Kingdom: where are we now and what's next?
    Fam Pract. 2022 Mar 28. pii: 6555054. doi: 10.1093.
    PubMed    


  26. HUANG X, Wang B, Shen H, Huang D, et al
    Farnesoid X receptor functions in cervical cancer via the p14(ARF)-mouse double minute 2-p53 pathway.
    Mol Biol Rep. 2022 Mar 28. pii: 10.1007/s11033-022-07201.
    PubMed    
    Abstract available

  27. AN J, Oh HE, Kim H, Lee JH, et al
    Significance of Altered Fatty Acid Transporter Expressions in Uterine Cervical Cancer and Its Precursor Lesions.
    Anticancer Res. 2022;42:2131-2137.
    PubMed    
    Abstract available

  28. WILEY RL, Bondre IL, Jalloul R, Klopp AH, et al
    Definitive vs palliative pelvic radiation for patients with newly diagnosed stage IVB cervical cancer treated with bevacizumab - An exploratory study.
    Gynecol Oncol Rep. 2022;40:100963.
    PubMed    
    Abstract available

  29. WANG X, Wang J, Yu M
    Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer.
    Comput Math Methods Med. 2022;2022:1902289.
    PubMed    
    Abstract available

  30. GARG PR, Srivastava S, Shumayla S, Kurian K, et al
    Women's Knowledge on Cervical Cancer Risk Factors and Symptoms: A Cross Sectional Study from Urban India.
    Asian Pac J Cancer Prev. 2022;23:1083-1090.
    PubMed    
    Abstract available

  31. AYATOLLAHI H, Ershadimoghaddam S, Naji S, Yekta Z, et al
    Comparison between Single Versus Twice Application of Topical 85% Trichloroacetic Acid in the Treatment of Cervical Intraepithelial Neoplasia; A Randomized Clinical Trial on Efficacy and Tolerability.
    Asian Pac J Cancer Prev. 2022;23:947-952.
    PubMed    
    Abstract available

  32. ALVA N N, A S, Shetty P, Mysorker V, et al
    A Study of Cytokeratin-7 Expression and Clinicopathological Correlation in Dysplasia and Squamous Cell Carcinoma of the Cervix.
    Asian Pac J Cancer Prev. 2022;23:885-891.
    PubMed    
    Abstract available

  33. WAHIDIN M, Febrianti R, Susanty F, Hasanah SR, et al
    Twelve Years Implementation of Cervical and Breast Cancer Screening Program in Indonesia.
    Asian Pac J Cancer Prev. 2022;23:829-837.
    PubMed    
    Abstract available

  34. AMIR SM, Idris IB, Mohd Yusoff H
    The Acceptance of Human Papillomavirus Self-Sampling Test among Muslim Women:A Systematic Review.
    Asian Pac J Cancer Prev. 2022;23:767-774.
    PubMed    
    Abstract available

  35. MENG Y, Lin S, Zhou Y, Yi X, et al
    RAB2A promotes cervical cancer progression as revealed by comprehensive analysis of HPV integration and proteome in longitudinal cervical samples.
    Clin Transl Med. 2022;12:e767.
    PubMed    


  36. ZHAO C, Shuai R, Ma L, Liu W, et al
    Improving cervical cancer classification with imbalanced datasets combining taming transformers with T2T-ViT.
    Multimed Tools Appl. 2022 Mar 19:1-36. doi: 10.1007/s11042-022-12670.
    PubMed    
    Abstract available

  37. KASUGA Y, Ikenoue S, Nishio H, Yamagami W, et al
    Adenocarcinoma in situ or early-stage cervical cancer is a risk factor for preterm delivery after cervical conization: a multicenter observational study.
    J Matern Fetal Neonatal Med. 2022 Mar 27:1-6. doi: 10.1080/14767058.2022.2056835
    PubMed    
    Abstract available

  38. QIN F, Pang H, Yu T, Luo Y, et al
    Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
    Technol Cancer Res Treat. 2022;21:15330338221086403.
    PubMed    
    Abstract available

  39. ZHANG X, Ma H, Lu X, Zhang Z, et al
    A Research Study to Measure the Efficacy of Terminating Cervical Cancer via Customized Optimum Pathway.
    J Healthc Eng. 2022;2022:7872915.
    PubMed    
    Abstract available

  40. HUO Z, Liu K, Zhang X, Liang Y, et al
    Discovery of pyrimidine-bridged CA-4 CBSIs for the treatment of cervical cancer in combination with cisplatin with significantly reduced nephrotoxicity.
    Eur J Med Chem. 2022;235:114271.
    PubMed    
    Abstract available

  41. SLADIC M, Taneska P, Cvjeticanin B, Velikonja M, et al
    Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  42. BARSOUK A, Saginala K, Aluru JS, Rawla P, et al
    US Cancer Screening Recommendations: Developments and the Impact of COVID-19.
    Med Sci (Basel). 2022;10.
    PubMed    
    Abstract available

  43. YOSHIMOTO Y, Murata K, Irie D, Ando K, et al
    A retrospective study of small-pelvis radiotherapy plus image-guided brachytherapy in stage I-II non-bulky cervical squamous cell carcinoma.
    J Radiat Res. 2022;63:290-295.
    PubMed    
    Abstract available

  44. KOOTI A, Abuei H, Farhadi A, Behzad-Behbahani A, et al
    Activating transcription factor 3 mediates apoptotic functions through a p53-independent pathway in human papillomavirus 18 infected HeLa cells.
    Virus Genes. 2022;58:88-97.
    PubMed    
    Abstract available

  45. SOLER M, Masch R, Saidu R, Cremer M, et al
    Thermal Ablation Treatment for Cervical Precancer (Cervical Intraepithelial Neoplasia Grade 2 or Higher [CIN2+]).
    Methods Mol Biol. 2022;2394:867-882.
    PubMed    
    Abstract available

  46. WELBY S, Rosillon D, Feng Y, Borys D, et al
    Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18-25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016.
    Expert Rev Vaccines. 2022;21:407-413.
    PubMed    
    Abstract available

  47. TURHAN CAKIR A, Sel G, Balci S, Harma M, et al
    Evaluation of HPV, smear and colposcopy results in patients with diabetes.
    Diabetes Metab Syndr. 2022;16:102335.
    PubMed    
    Abstract available

  48. WANG W, Kothari S, Baay M, Garland SM, et al
    Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources.
    Expert Rev Vaccines. 2022;21:227-240.
    PubMed    
    Abstract available

  49. JONES TE, Austin RM
    The significant remaining challenge of screening for cervical glandular neoplasia.
    J Am Soc Cytopathol. 2022;11:1-2.
    PubMed    


  50. MOHAPATRA D, Pratap R, Pandey V, Dubey PK, et al
    Tinospora cordifolia Leaves Derived Carbon dots for Cancer Cell Bioimaging, Free radical Scavenging, and Fe(3+) Sensing Applications.
    J Fluoresc. 2022;32:275-292.
    PubMed    
    Abstract available

  51. SHING JZ, Griffin MR, Chang RS, Beeghly-Fadiel A, et al
    Human Papillomavirus Vaccine Impact on Cervical Precancers in a Low-Vaccination Population.
    Am J Prev Med. 2022;62:395-403.
    PubMed    
    Abstract available

  52. ALDANA-CABALLERO A, Marcos-Tejedor F, Mayordomo R
    Diagnostic techniques in HPV infections and the need to implement them in plantar lesions: A systematic review.
    Expert Rev Mol Diagn. 2021;21:1341-1348.
    PubMed    
    Abstract available

  53. MIRZA S, Kalluchi A, Raza M, Saleem I, et al
    Ecdysoneless Protein Regulates Viral and Cellular mRNA Splicing to Promote Cervical Oncogenesis.
    Mol Cancer Res. 2022;20:305-318.
    PubMed    
    Abstract available

  54. HOU YM, Wang XP, Shen CC, Chen LT, et al
    Cervical carcinoma progression is aggravated by lncRNA ZNF281 by binding KLF15.
    Eur Rev Med Pharmacol Sci. 2021;25:5610-5618.
    PubMed    
    Abstract available

  55. TOMALCZYK A, Tomasik B, Fijuth J, Moszynska-Zielinska M, et al
    Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions.
    Arch Gynecol Obstet. 2022;305:955-961.
    PubMed    
    Abstract available

  56. LIN M, Narkcham S, Jones A, Armylagos D, et al
    False-negative Papanicolaou tests in women with biopsy-proven invasive endocervical adenocarcinoma/adenocarcinoma in situ: a retrospective analysis with assessment of interobserver agreement.
    J Am Soc Cytopathol. 2022;11:3-12.
    PubMed    
    Abstract available

  57. LASHMANOVA N, Braun A, Cheng L, Gattuso P, et al
    Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
    J Am Soc Cytopathol. 2022;11:13-20.
    PubMed    
    Abstract available

  58. CHEN L, Lucas E, Zhang X, Liu Q, et al
    Programmed death-ligand 1 expression in human papillomavirus-independent cervical adenocarcinoma and its prognostic significance.
    Histopathology. 2022;80:338-347.
    PubMed    
    Abstract available

  59. LIU J, Liang T, Peng Y, Peng G, et al
    Segmentation of acetowhite region in uterine cervical image based on deep learning.
    Technol Health Care. 2022;30:469-482.
    PubMed    
    Abstract available

  60. CAO CH, Liu R, Lin XR, Luo JQ, et al
    LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma.
    Int J Biol Sci. 2021;17:1744-1756.
    PubMed    
    Abstract available

  61. TAYLOR SN, Eckert K, Rucki AA, VanSickler M, et al
    Evaluation of the Onclarity HPV assay on the high-throughput COR system.
    Expert Rev Mol Diagn. 2021;21:333-342.
    PubMed    
    Abstract available

  62. LUO H, Song Y, Zhang JA, Liu Y, et al
    MAT2A facilitates PDCD6 methylation and promotes cell growth under glucose deprivation in cervical cancer.
    Cell Death Discov. 2022;8:176.
    PubMed    
    Abstract available

  63. WU X, Qiu L, Lou W, Wang X, et al
    A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial.
    Trials. 2022;23:269.
    PubMed    
    Abstract available

  64. AMEMIYA T, Shibata K, Takahashi J, Watanabe M, et al
    Glycolytic Oscillations in HeLa Cervical Cancer Cell Spheroids.
    FEBS J. 2022 Apr 8. doi: 10.1111/febs.16454.
    PubMed    
    Abstract available

  65. MORADI S, Taherinezhad Ledari A
    Encouraging women to do cervical cancer screening: a secondary preventive intervention with a multitude of behavioural dimensions.
    Evid Based Nurs. 2022 Apr 7. pii: ebnurs-2021-103510.
    PubMed    


  66. WANG C, Qin X, Gong G, Wang L, et al
    Correlation between changes of pelvic bone marrow fat content and hematological toxicity in concurrent chemoradiotherapy for cervical cancer.
    Radiat Oncol. 2022;17:70.
    PubMed    
    Abstract available

  67. BAI LP, Chen YL, Zheng A
    Pharmacological targeting transient receptor potential canonical channel 6 modulates biological behaviors for cervical cancer HeLa and SiHA cell.
    Cancer Cell Int. 2022;22:145.
    PubMed    
    Abstract available

  68. ORTIZ-MENDOZA CM
    Cervical Cancer Screening in Patients with Total Hysterectomy in a Diagnostic Center at Mexico City.
    Int J Prev Med. 2022;13:29.
    PubMed    
    Abstract available

  69. MA Y, Zhang X, Yang J, Jin Y, et al
    Comprehensive Molecular Analyses of a TNF Family-Based Gene Signature as a Potentially Novel Prognostic Biomarker for Cervical Cancer.
    Front Oncol. 2022;12:854615.
    PubMed    
    Abstract available

  70. ZHAO Y, Lan Y, Chi Y, Yang B, et al
    Downregulation of Circ-CEP128 Enhances the Paclitaxel Sensitivity of Cervical Cancer Through Regulating miR-432-5p/MCL1.
    Biochem Genet. 2022 Apr 7. pii: 10.1007/s10528-022-10201.
    PubMed    
    Abstract available

  71. WU J, Lakomy DS, Fellman BM, Salcedo MP, et al
    Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment.
    Pract Radiat Oncol. 2022 Apr 4. pii: S1879-8500(22)00124.
    PubMed    
    Abstract available

  72. QU X, Tao J, Xie J
    Circ_0009035 regulates the progression of cervical cancer by targeting miR-1305/CREBRF axis.
    Anticancer Drugs. 2022 Apr 8. pii: 00001813-990000000-00001.
    PubMed    
    Abstract available

  73. WANG C, Wang Y, Liu C, Meng X, et al
    Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9.
    Bioengineered. 2022;13:9495-9507.
    PubMed    
    Abstract available

  74. ZOU MJ, Cheng XR, Liu RF
    lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p/HDGF.
    J Obstet Gynaecol Res. 2022 Apr 7. doi: 10.1111/jog.15245.
    PubMed    
    Abstract available

  75. CHOPRA S, Goda JS, Mittal P, Mulani J, et al
    Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial.
    BMJ Open. 2022;12:e055765.
    PubMed    
    Abstract available

  76. ARYA R, Hong D, Schultz O, Jutzy JM, et al
    Opioid Use in Patients With Cervical Cancer at Two Urban Medical Centers.
    Adv Radiat Oncol. 2021;7:100833.
    PubMed    
    Abstract available

  77. KARANJA-CHEGE CM
    HPV Vaccination in Kenya: The Challenges Faced and Strategies to Increase Uptake.
    Front Public Health. 2022;10:802947.
    PubMed    
    Abstract available

  78. ZHANG Z, Zhang C, Xiao L, Zhang S, et al
    Diagnosis of Early Cervical Cancer with a Multimodal Magnetic Resonance Image under the Artificial Intelligence Algorithm.
    Contrast Media Mol Imaging. 2022;2022:6495309.
    PubMed    
    Abstract available

  79. WONG V, Abreu-Diaz M, Kaur M, El-Hosseiny S, et al
    Shoulder and Upper Back Pain: An Unusual Initial Presentation of Rare Stage IV Small Cell Neuroendocrine Cervical Cancer.
    Cureus. 2022;14:e22708.
    PubMed    
    Abstract available

  80. NOMELINI RS, Mota SDS, Murta EFC
    Absolute band neutrophils count is a predictor of overall survival in advanced uterine cervical cancer.
    Arch Gynecol Obstet. 2022 Apr 7. pii: 10.1007/s00404-022-06545.
    PubMed    
    Abstract available

  81. MULLAPALLY SK, Digumarti L, Digumarti R
    Cervical Cancer in Low- and Middle-Income Countries: A Multidimensional Approach to Closing the Gaps.
    JCO Oncol Pract. 2022 Apr 6:OP2200156. doi: 10.1200/OP.22.00156.
    PubMed    


  82. GALVAO MPSP, Araujo TME, Rocha SSD
    Knowledge, attitudes, and practices of adolescents regarding human papillomavirus.
    Rev Saude Publica. 2022;56:12.
    PubMed    
    Abstract available

  83. CHENG X, Shen C, Liao Z
    High Expression of Circular RNA-Mitochondrial tRNA Translation Optimization 1 Assists the Diagnosis of High-Risk Human Papillomavirus Infection in Cervical Cancer.
    J Low Genit Tract Dis. 2022 Apr 5. pii: 00128360-990000000-00002.
    PubMed    
    Abstract available

  84. MBUYISA SS, Khumalo TL, Makhathini BS, Moodley J, et al
    Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg.
    S Afr Fam Pract (2004). 2022;64:e1-e5.
    PubMed    
    Abstract available

  85. RAWAT A, Mithani N, Sanders C, Namugosa R, et al
    "We Shall Tell them with Love, Inform them what we have Learnt and then Allow them to go" - Men's Perspectives of Self-Collected Cervical Cancer Screening in Rural Uganda: A Qualitative Inquiry.
    J Cancer Educ. 2022 Apr 6. pii: 10.1007/s13187-022-02163.
    PubMed    
    Abstract available

  86. WANG L, Zhou Y, Cao C, Lin S, et al
    The exon 12-containing LHX6 isoforms promote cervical cancer cell proliferation by regulating the MAPK signaling pathway.
    Cancer Med. 2022 Apr 5. doi: 10.1002/cam4.4734.
    PubMed    
    Abstract available

  87. MIHALY-VAJDA R, Csakvari T, Ponusz-Kovacs D, Varga V, et al
    Comment to: Inequalities in adherence to cervical cancer screening in Portugal.
    Eur J Cancer Prev. 2022;31:310-312.
    PubMed    


  88. MENTZER AJ, Brenner N, Allen N, Littlejohns TJ, et al
    Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank.
    Nat Commun. 2022;13:1818.
    PubMed    
    Abstract available

  89. COSMAS NT, Nimzing L, Egah D, Famooto A, et al
    Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria.
    BMC Infect Dis. 2022;22:340.
    PubMed    
    Abstract available

  90. TJALMA WAA
    When to use dual staining in cervical cancer screening?
    J Cancer Res Ther. 2022;18:318-319.
    PubMed    


  91. KUMAR S, Sucheta, Saklani B, Archana, et al
    Post hysterectomy mesonephric carcinoma: A case report and literature review.
    J Cancer Res Ther. 2022;18:277-279.
    PubMed    
    Abstract available

  92. GIOE A, Arciuolo D, Carbone V, Zannoni G, et al
    Isolated humeral metastasis in cervical cancer: A case report and review of the literature.
    J Cancer Res Ther. 2022;18:273-276.
    PubMed    
    Abstract available

  93. KIATTIKUL CL, Narayan K, Bernshaw D, Dyk SV, et al
    Tumor control after palliative hypofractionated, "Quad-shot," external beam radiotherapy followed by brachytherapy: An effective approach in medically compromised and/or elderly patients with cervix cancer.
    J Cancer Res Ther. 2022;18:173-179.
    PubMed    
    Abstract available

  94. RAJU K, Raghuveer CV, Sheela SR, Natarajan A, et al
    Evaluation of enzyme-linked immunosorbent assay plasma p16INK4a protein in squamous cell carcinoma in uterine cervix: A case-control study.
    J Cancer Res Ther. 2022;18:152-157.
    PubMed    
    Abstract available

  95. KANJAK J, Likitdee N, Kietpeerakool C, Temtanakitpaisan A, et al
    Evaluation of mobile health applications for cervical cancer in the digital marketplace.
    Obstet Gynecol Sci. 2022 Apr 5. pii: ogs.22037. doi: 10.5468/ogs.22037.
    PubMed    
    Abstract available

  96. BHATTACHARJEE R, Das SS, Biswal SS, Nath A, et al
    Mechanistic Role of HPV-Associated Early Proteins in Cervical Cancer: Molecular Pathways and Targeted Therapeutic Strategies.
    Crit Rev Oncol Hematol. 2022 Apr 2:103675. doi: 10.1016/j.critrevonc.2022.103675
    PubMed    
    Abstract available

  97. YAHYA A, Mustapha A, Kolawole AOD, Oguntayo AO, et al
    Cervical Cancer Screening in a Human Immunodeficiency Virus Treatment Centre in Zaria North-Western Nigeria.
    West Afr J Med. 2022;39:291-298.
    PubMed    
    Abstract available

  98. MANSOUR MB, Crone MR, Sert E, van Weert HC, et al
    Smoking cessation strategy in the national cervical cancer screening program (SUCCESS): study protocol for a pragmatic cluster randomised trial and process evaluation in Dutch general practice.
    BMJ Open. 2022;12:e055812.
    PubMed    
    Abstract available

  99. PETIGNAT P, Kenfack B, Wisniak A, Saiji E, et al
    ABCD criteria to improve visual inspection with acetic acid (VIA) triage in HPV-positive women: a prospective study of diagnostic accuracy.
    BMJ Open. 2022;12:e052504.
    PubMed    
    Abstract available

  100. CHENG M, Wang H, Zhao Y, Li G, et al
    Efficacy and Prognostic Factors for Response to PD-1 Inhibitors in Advanced Cervical Carcinoma: A Retrospective Study.
    Drug Des Devel Ther. 2022;16:887-897.
    PubMed    
    Abstract available

  101. WANG Y, Du F, Xie Z, Lai J, et al
    Circ_0005576 Exerts an Oncogenic Role in Cervical Cancer via miR-1305-Dependent Regulation of PAIP1.
    Reprod Sci. 2022 Apr 4. pii: 10.1007/s43032-022-00925.
    PubMed    
    Abstract available

  102. AHANGARI S, Littrup Andersen F, Liv Hansen N, Jakobi Nottrup T, et al
    Multi-parametric PET/MRI for enhanced tumor characterization of patients with cervical cancer.
    Eur J Hybrid Imaging. 2022;6:7.
    PubMed    
    Abstract available

  103. BEYER S, Wehrmann M, Meister S, Kolben TM, et al
    Galectin-8 and -9 as prognostic factors for cervical cancer.
    Arch Gynecol Obstet. 2022 Apr 4. pii: 10.1007/s00404-022-06449.
    PubMed    
    Abstract available

  104. FRANCIOSI MLM, do Carmo TIT, Zanini D, Cardoso AM, et al
    Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets.
    Inflamm Res. 2022 Apr 4. pii: 10.1007/s00011-022-01560.
    PubMed    
    Abstract available

  105. YOSHIMOTO D, Taguchi A, Tanikawa M, Sone K, et al
    Recurrent cervical cancer with PD-L1 amplification treated with nivolumab: A case enrolled in the BELIEVE trial.
    J Obstet Gynaecol Res. 2022 Apr 3. doi: 10.1111/jog.15240.
    PubMed    
    Abstract available

  106. QIAO Y, Li H, Peng B
    Neoadjuvant and Adjuvant Treatments Compared to Concurrent Chemoradiotherapy for Patients With Locally Advanced Cervical Cancer: A Bayesian Network Meta-Analysis.
    Front Oncol. 2022;12:745522.
    PubMed    
    Abstract available

  107. CHI Y, Pan Y, Zhang N, Han D, et al
    Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.
    Front Oncol. 2022;12:841980.
    PubMed    
    Abstract available

  108. YI J, Liu Z, Wang L, Zhang X, et al
    Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis.
    Front Oncol. 2022;12:857375.
    PubMed    
    Abstract available

  109. YANG X, Ren H, Fu J
    Combinations of radiotherapy with immunotherapy in cervical cancer.
    J Cancer. 2022;13:1480-1489.
    PubMed    
    Abstract available

  110. YIN S, Zhang Q, Wang Y, Li S, et al
    MicroRNA-130a regulated by HPV18 E6 promotes proliferation and invasion of cervical cancer cells by targeting TIMP2.
    Exp Ther Med. 2022;23:316.
    PubMed    
    Abstract available

  111. CASTANON A, Rebolj M, Pesola F, Pearmain P, et al
    COVID-19 disruption to cervical cancer screening in England.
    J Med Screen. 2022 Apr 4:9691413221090892. doi: 10.1177/09691413221090892.
    PubMed    
    Abstract available

  112. DANIEL D, Wickerham A, Fitzgerald EA, Kue J, et al
    Interventions to Eliminate Cervical Cancer in Nicaragua: An Integrative Review of the Literature.
    Hisp Health Care Int. 2022 Apr 4:15404153221081280.
    PubMed    
    Abstract available

  113. LI P, Feng S, Zhou G, Zhang L, et al
    Clinical Study of Sentinel Lymph Node Detection to Evaluate Pelvic Lymph Node Metastasis to Determine the Prognosis of Patients with Early Cervical Cancer.
    Appl Bionics Biomech. 2022;2022:8394049.
    PubMed    
    Abstract available

  114. HUA C, Zheng Q, Zhu J, Chen S, et al
    Human Papillomavirus Type 16 Early Protein E7 Activates Autophagy through Inhibition of Dual-Specificity Phosphatase 5.
    Oxid Med Cell Longev. 2022;2022:1863098.
    PubMed    
    Abstract available

  115. QUAN C, Liang S, Feng Z, Zhu J, et al
    Surgical and oncologic outcomes between laparoscopic and radical abdominal hysterectomy for IB1-IIA2 cervical cancer.
    Asian J Surg. 2022 Mar 31. pii: S1015-9584(22)00047.
    PubMed    
    Abstract available

  116. RAMOGOLA-MASIRE D, Grover S, Mathoma A, Monare B, et al
    Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.
    BMC Womens Health. 2022;22:100.
    PubMed    
    Abstract available

  117. FEDERICO A, Anchora LP, Scambia G, Ferrandina G, et al
    ASO Author Reflections: Role of Adjuvant Surgery in Locally Advanced Cervical Cancer: An Unresolved Issue.
    Ann Surg Oncol. 2022 Apr 2. pii: 10.1245/s10434-022-11620.
    PubMed    


  118. SHI B, Dong JN, Zhang LX, Li CP, et al
    A Combination Analysis of IVIM-DWI Biomarkers and T2WI-Based Texture Features for Tumor Differentiation Grade of Cervical Squamous Cell Carcinoma.
    Contrast Media Mol Imaging. 2022;2022:2837905.
    PubMed    
    Abstract available

  119. ZHAO Y, Sun PL, He YY, Gao HW, et al
    [Clinicopathological features and progression of so-called adenoid cystic carcinoma of the cervix].
    Zhonghua Bing Li Xue Za Zhi. 2022;51:385-388.
    PubMed    


  120. JIN J, Luo RK, Zhao J, Ning YQ, et al
    [Prevalence and frequencies of human papilloma virus types in adenocarcinoma in situ of the uterine cervix].
    Zhonghua Bing Li Xue Za Zhi. 2022;51:338-343.
    PubMed    
    Abstract available

  121. IEZZONI LI
    Cancer detection, diagnosis, and treatment for adults with disabilities.
    Lancet Oncol. 2022;23:e164-e173.
    PubMed    
    Abstract available

  122. NORMILE D
    Japan reboots HPV vaccination drive after 9-year gap.
    Science. 2022;376:14.
    PubMed    
    Abstract available

  123. SADAT LARIJANI M, Omrani MD, Soleimani R, Bavand A, et al
    Determination of Human Papillomavirus Type 18 Lineage of E6: A Population Study from Iran.
    Biomed Res Int. 2022;2022:2839708.
    PubMed    
    Abstract available

  124. ZENG H, Liu M, Xiao L, Zhang X, et al
    Effectiveness and immune responses of focused ultrasound ablation for cervical intraepithelial neoplasia.
    Int J Hyperthermia. 2022;39:539-546.
    PubMed    
    Abstract available

  125. FERREIRA MDC, Sarti FM, Barros MBA
    Social inequalities in the incidence, mortality, and survival of neoplasms in women from a municipality in Southeastern Brazil.
    Cad Saude Publica. 2022;38:e00107521.
    PubMed    
    Abstract available

  126. HUANG Y, Wu Q, Tan X
    Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.
    Bioengineered. 2022;13:6955-6965.
    PubMed    
    Abstract available

  127. DUAN D, Wang Y, Pan D, Jin X, et al
    Rheumatoid arthritis drug sinomenine induces apoptosis of cervical tumor cells by targeting thioredoxin reductase in vitro and in vivo.
    Bioorg Chem. 2022;122:105711.
    PubMed    
    Abstract available

  128. ZHANG C, Quan Y, Yang L, Bai Y, et al
    6-Methoxyflavone induces S-phase arrest through the CCNA2/CDK2/p21CIP1 signaling pathway in HeLa cells.
    Bioengineered. 2022;13:7277-7292.
    PubMed    
    Abstract available

  129. DAS M
    Cancer control in Botswana.
    Lancet Oncol. 2022;23:455.
    PubMed    


  130. MOSSERI J, Hocquemiller R, Mergui JL, Uzan C, et al
    Laser conization for cervical intraepithelial neoplasia: Effectiveness and obstetric outcomes.
    J Gynecol Obstet Hum Reprod. 2022;51:102341.
    PubMed    
    Abstract available

  131. PATTERSON JG, Borger TN, Burris JL, Conaway M, et al
    A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the "Break Free" program.
    Addict Sci Clin Pract. 2022;17:11.
    PubMed    
    Abstract available

  132. BIGGS KV, Soo Hoo S, Kodampur M
    Mechanical dilatation of the stenosed cervix under local anesthesia: A prospective case series.
    J Obstet Gynaecol Res. 2022;48:956-965.
    PubMed    
    Abstract available

  133. MAFRA DA COSTA A, Hernandes ICP, Weiderpass E, Soerjomataram I, et al
    Cancer Statistics over Time in Northwestern Sao Paulo State, Brazil: Incidence and Mortality.
    Cancer Epidemiol Biomarkers Prev. 2022;31:707-714.
    PubMed    
    Abstract available

  134. PEDERSEN H, Ejegod DM, Quint W, Xu L, et al
    Clinical Performance of the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework.
    J Mol Diagn. 2022;24:365-373.
    PubMed    
    Abstract available

  135. WHOP LJ, Butler TL, Lee N, Cunningham J, et al
    Aboriginal and Torres Strait Islander women's views of cervical screening by self-collection: a qualitative study.
    Aust N Z J Public Health. 2022;46:161-169.
    PubMed    
    Abstract available

  136. KIM E, Kojima N, Vangala S, Dermenchyan A, et al
    Impact of COVID-19 on Primary Care Quality Measures in an Academic Integrated Health System.
    J Gen Intern Med. 2022;37:1161-1168.
    PubMed    
    Abstract available

  137. BUSS LF, Cury L, Ribeiro CM, Silva GAE, et al
    Access to colposcopy in the State of Sao Paulo, Brazil: probabilistic linkage study of administrative data.
    Cad Saude Publica. 2022;38:e00304820.
    PubMed    
    Abstract available

  138. PEREZ-MONTIEL D, Alvarado Cabrero I, Barquet S, Prada D, et al
    Acantholytic squamous cell carcinomas of the cervix: A case series.
    Ann Diagn Pathol. 2022;57:151866.
    PubMed    
    Abstract available

  139. FU L, Xia W, Shi W, Cao GX, et al
    Deep learning based cervical screening by the cross-modal integration of colposcopy, cytology, and HPV test.
    Int J Med Inform. 2022;159:104675.
    PubMed    
    Abstract available

  140. KULKARNI A, Chen L, Melamed A, Hershman DL, et al
    Trends in human papillomavirus vaccination among women aged 27 to 45 years, from 2017 to 2019.
    Am J Obstet Gynecol. 2022;226:568-570.
    PubMed    


  141. QIN Y, Li Q, Ke X, Zhang Y, et al
    Clearance of HR-HPV within one year after focused ultrasound or loop electrosurgical excision procedure in patients with HSIL under 30.
    Int J Hyperthermia. 2022;39:15-21.
    PubMed    
    Abstract available

  142. STAATS PN, Davey DD, Witt BL, Ghofrani M, et al
    Performance of specific morphologic features in distinguishing low-grade squamous intraepithelial lesions from high-grade squamous intraepithelial lesions in borderline cases: a College of American Pathologists Cytopathology Committee multiobserver st
    J Am Soc Cytopathol. 2022;11:102-113.
    PubMed    
    Abstract available

  143. TAO X, Austin RM, Yu T, Zhong F, et al
    Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.
    Cancer Cytopathol. 2022;130:248-258.
    PubMed    
    Abstract available

  144. LANG L, Jia Y, Duan Z, Wu J, et al
    The role of endocervical curettage in detection and treatment of cervical canal lesions.
    Histol Histopathol. 2022;37:63-68.
    PubMed    
    Abstract available

  145. ASAKA S, Nakajima T, Ida K, Asaka R, et al
    Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and PAX8 in association with HPV status.
    Virchows Arch. 2022;480:269-280.
    PubMed    
    Abstract available

  146. BIANCHI C, Auzzi N, Turrini I, De Magnis A, et al
    CO2 laser colposcopic guided surgery for the see and treat management of VHSIL: a preliminary experience.
    Lasers Med Sci. 2022;37:1635-1641.
    PubMed    
    Abstract available

  147. DARE AJ, Knapp GC, Romanoff A, Olasehinde O, et al
    High-burden Cancers in Middle-income Countries: A Review of Prevention and Early Detection Strategies Targeting At-risk Populations.
    Cancer Prev Res (Phila). 2021;14:1061-1074.
    PubMed    
    Abstract available

  148. CAICEDO-MARTINEZ M, Fernandez-Deaza G, Ordonez-Reyes C, Olejua P, et al
    High-risk human papillomavirus infection among women living with HIV in Latin America and the Caribbean: A systematic review and meta-analysis.
    Int J STD AIDS. 2021;32:1278-1289.
    PubMed    
    Abstract available

  149. SCHULTHEIS AM, de Bruijn I, Selenica P, Macedo GS, et al
    Genomic characterization of small cell carcinomas of the uterine cervix.
    Mol Oncol. 2022;16:833-845.
    PubMed    
    Abstract available

  150. MURPHY SJ, Walsh M, Das A
    Human papilloma virus and vaccine: knowledge and acceptability in an Irish general hospital-a questionnaire-based study.
    Ir J Med Sci. 2022;191:659-663.
    PubMed    
    Abstract available

  151. BHAT S, Adiga D, Shukla V, Guruprasad KP, et al
    Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence.
    Cell Biol Toxicol. 2022;38:237-258.
    PubMed    
    Abstract available

  152. AHMAD A, Ansari IA
    Intervening Stemness and Angiogenesis in Cervical Carcinoma: Revisiting the Efficacy of Natural Compounds.
    Endocr Metab Immune Disord Drug Targets. 2021;21:1709-1712.
    PubMed    


  153. LAWAL IO, Ololade KO, Popoola GO, Ankrah AO, et al
    18F-FDG-PET/CT imaging of uterine cervical cancer recurrence in women with and without HIV infection.
    Q J Nucl Med Mol Imaging. 2022;66:52-60.
    PubMed    
    Abstract available

  154. KEPKA D, Bodson J, Lai D, Sanchez-Birkhead AC, et al
    Diverse caregivers' HPV vaccine-related awareness and knowledge.
    Ethn Health. 2021;26:811-826.
    PubMed    
    Abstract available

  155. PIERRE-VICTOR D, Stephens D, Gabbidon K, Jean-Baptiste N, et al
    Conversations about sexual activity within Haitian families: implications for HPV vaccine uptake.
    Ethn Health. 2021;26:571-584.
    PubMed    
    Abstract available

  156. LEE H, Kim D, Kiang PN, Cooley ME, et al
    Awareness, knowledge, social norms, and vaccination intentions among Khmer mother-daughter pairs.
    Ethn Health. 2021;26:379-391.
    PubMed    
    Abstract available

  157. SUZUKI Y, Sukegawa A, Ueda Y, Sekine M, et al
    Effect of a web-based cervical cancer survivor story on the willingness and behavioral change for Human Papillomavirus Vaccination among Japanese parents with at least one daughter aged 11 to 18 years old: Randomized Controlled Trial.
    JMIR Public Health Surveill. 2022 Apr 12. doi: 10.2196/34715.
    PubMed    
    Abstract available

  158. WANG H, Wang D, Wei Q, Li C, et al
    Long non-coding RNAs PGM5-AS1 upregulates Decorin (DCN) to inhibit cervical cancer progression by sponging miR-4284.
    Bioengineered. 2022;13:9872-9884.
    PubMed    
    Abstract available

  159. LIU C, Li X, Li A, Zou W, et al
    Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer.
    J Immunol Res. 2022;2022:9621466.
    PubMed    
    Abstract available

  160. BEKELE HT, Nuri A, Abera L
    Knowledge, Attitude, and Practice Toward Cervical Cancer Screening and Associated Factors Among College and University Female Students in Dire Dawa City, Eastern Ethiopia.
    Cancer Inform. 2022;21:11769351221084808.
    PubMed    
    Abstract available

  161. ZHANG H, Han WJ, Zhang ZL
    The Importance of Tumor Necrosis Factor-alpha-Induced Protein-8 Like-2 in the Pathogenesis of Cervical Cancer and Preeclampsia via Regulation of Cell Invasion.
    Tohoku J Exp Med. 2022 Apr 14. doi: 10.1620/tjem.2022.
    PubMed    


  162. LIN X, Wang F, Chen J, Liu J, et al
    N(6)-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance.
    Mil Med Res. 2022;9:19.
    PubMed    
    Abstract available

  163. CHEN S, Shu S
    Manganese Deficiency Promotes the Progression of Invasive Adenocarcinoma of the Cervix by Enhancing the Inflammatory Response.
    Ann Clin Lab Sci. 2022;52:269-277.
    PubMed    
    Abstract available

  164. YANG C, Xie J, Chen Q, Yang Y, et al
    Down-regulated Circ_0000190 promotes cervical cancer by facilitating the activity of proto-oncogene protein EIF4E.
    Cell Cycle. 2022 Apr 13:1-11. doi: 10.1080/15384101.2021.2018212.
    PubMed    
    Abstract available

  165. NIE Y, Liu D, Yang W, Li Y, et al
    Increased expression of TIGIT and KLRG1 correlates with impaired CD56(bright) NK cell immunity in HPV16-related cervical intraepithelial neoplasia.
    Virol J. 2022;19:68.
    PubMed    
    Abstract available

  166. COOLEY JJP, Maguire FB, Abrahao R, Morris CR, et al
    Late-Stage Cervical Cancer Diagnosis in Young Adults in California following the Affordable Care Act.
    J Registry Manag. 2021;48:144-145.
    PubMed    
    Abstract available

  167. MONK BJ, Enomoto T, Martin Kast W, McCormack M, et al
    Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials.
    Cancer Treat Rev. 2022;106:102385.
    PubMed    
    Abstract available

  168. ZHU Y
    Human Papillomavirus (HPV) Entry Inhibitors.
    Adv Exp Med Biol. 2022;1366:223-239.
    PubMed    
    Abstract available

  169. ZHOU J, Yang W, Gu S, Quan H, et al
    [Automatic Post-operative Cervical Cancer Target Area and Organ at Risk Outlining Based on Fusion Convolutional Neural Network].
    Zhongguo Yi Liao Qi Xie Za Zhi. 2022;46:132-136.
    PubMed    
    Abstract available

  170. ZENG W, Huang L, Lin H, Pan R, et al
    Development and Validation of a Nomogram for Predicting Postoperative Distant Metastasis in Patients with Cervical Cancer.
    Med Sci Monit. 2022;28:e933379.
    PubMed    
    Abstract available

  171. LIU Y, Tu H, Zhang L, Zhong M, et al
    The best postoperative adjuvant therapy for patients with early stage cervical adenosquamous carcinoma.
    BMC Womens Health. 2022;22:112.
    PubMed    
    Abstract available

  172. TIITI TA, Bogers J, Lebelo RL
    Knowledge of Human Papillomavirus and Cervical Cancer among Women Attending Gynecology Clinics in Pretoria, South Africa.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  173. DA SILVA DCB, Garnelo L, Herkrath FJ
    Barriers to Access the Pap Smear Test for Cervical Cancer Screening in Rural Riverside Populations Covered by a Fluvial Primary Healthcare Team in the Amazon.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  174. REZA MS, Harun-Or-Roshid M, Islam MA, Hossen MA, et al
    Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  175. YOON J, Kim H, Jeong YI, Yang HS, et al
    CD44 Receptor-Mediated/Reactive Oxygen Species-Sensitive Delivery of Nanophotosensitizers against Cervical Cancer Cells.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  176. TURINETTO M, Valsecchi AA, Tuninetti V, Scotto G, et al
    Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  177. WAROWICKA A, Broniarczyk J, Weglewska M, Kwasniewski W, et al
    Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  178. YANG Q, Al-Hendy A
    The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer.
    Cells. 2022;11.
    PubMed    
    Abstract available

  179. CHEN YH, Wu JX, Yang SF, Yang CK, et al
    Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  180. D'CUNHA P, Albuquerque K, Xi Y, Pinho DF, et al
    Correlating Quantitative Para-Aortic Lymph Node Computed Tomography Parameters With Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Staging: Possible Solution for Resource Constrained Countries.
    J Comput Assist Tomogr. 2022 Apr 8. pii: 00004728-990000000-00011.
    PubMed    
    Abstract available

  181. KOHUT AY, Kuhn T, Conrad LB, Chua KJ, et al
    30-day postoperative adverse events in minimally invasive versus open abdominal radical hysterectomy for early-stage cervical cancer.
    J Minim Invasive Gynecol. 2022 Apr 8. pii: S1553-4650(22)00121.
    PubMed    
    Abstract available

  182. FIELDEN N, Holch P
    'Exploring the Influence of Social Media Influencers on Intention to Attend Cervical Screening in the UK: Utilising the Theory of Planned Behaviour'.
    Cancer Control. 2022;29:10732748221079480.
    PubMed    
    Abstract available

  183. LEHRER S, Rheinstein PH
    PTPN14 Mutations and Cervical Cancer.
    Cancer Diagn Progn. 2021;1:275-277.
    PubMed    
    Abstract available

  184. FACONDO G, Vullo G, DE Sanctis V, Valeriani M, et al
    Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy.
    Cancer Diagn Progn. 2021;1:53-60.
    PubMed    
    Abstract available

  185. ZHANG L, Tan W, Yang H, Zhang S, et al
    Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer.
    Front Oncol. 2022;12:831949.
    PubMed    
    Abstract available

  186. WANG XY, Mao HW, Guan XH, Huang QM, et al
    TRIM65 Promotes Cervical Cancer Through Selectively Degrading p53-Mediated Inhibition of Autophagy and Apoptosis.
    Front Oncol. 2022;12:853935.
    PubMed    
    Abstract available

  187. SUGA T, Abe T, Oiwa H
    A Case of Anti-nuclear Matrix Protein 2 Antibody-positive Dermatomyositis Associated with Cervical Cancer Recurrence after 6 Years of Stable Disease.
    Intern Med. 2022 Apr 9. doi: 10.2169/internalmedicine.9415.
    PubMed    
    Abstract available

  188. LI X, Chen B, Huang A, Ren C, et al
    LncRNA HCP5 enhances the proliferation and migration of cervical cancer via miR-216a-5p/CDC42 axis.
    J Cancer. 2022;13:1882-1894.
    PubMed    
    Abstract available

  189. POUREBRAHIM-ALAMDARI P, Mehrabi E, Nourizadeh R, Esmaeilpour K, et al
    The Effect of Face-to-Face and Phone Call Motivational Interviewing on Cervical Cancer Screening.
    Cancer Nurs. 2022 Apr 9. pii: 00002820-990000000-00017.
    PubMed    
    Abstract available

  190. PRAMANIK R, Biswas M, Sen S, Souza Junior LA, et al
    A fuzzy distance-based ensemble of deep models for cervical cancer detection.
    Comput Methods Programs Biomed. 2022;219:106776.
    PubMed    
    Abstract available

  191. FEDERICO A, Anchora LP, Gallotta V, Fanfani F, et al
    ASO Visual Abstract: Clinical Impact of Pathological Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study.
    Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11676.
    PubMed    


  192. CICERON AC, Jeon MJ, Monroe AK, Clausen ME, et al
    HPV knowledge, screening barriers and facilitators, and sources of health information among women living with HIV: perspectives from the DC community during the COVID-19 pandemic.
    BMC Womens Health. 2022;22:110.
    PubMed    
    Abstract available

  193. MANSOUR MBL, Crone MR, van Weert HC, Chavannes NH, et al
    Stop smoking advice by practice assistants after routine cervical screening in general practice: A qualitative exploration of potential barriers and enablers.
    Eur J Gen Pract. 2022;28:56-65.
    PubMed    
    Abstract available

  194. TANAKA K, Kogure G, Onuki M, Matsumoto K, et al
    Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan.
    Viruses. 2022;14.
    PubMed    
    Abstract available

  195. BRENES D, Barberan CJ, Hunt B, Parra SG, et al
    Multi-task network for automated analysis of high-resolution endomicroscopy images to detect cervical precancer and cancer.
    Comput Med Imaging Graph. 2022;97:102052.
    PubMed    
    Abstract available

  196. DHAMIJA E, Baby A, Bhatla N, Pulappadi VP, et al
    Radiological evaluation of metastatic lymph nodes in carcinoma cervix with emphasis on their infiltrative pattern.
    Indian J Med Res. 2021;154:383-390.
    PubMed    
    Abstract available

  197. JAVED S, Sood S, Rai B, Bhattacharyya S, et al
    ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy.
    Indian J Med Res. 2021;154:367-374.
    PubMed    
    Abstract available

  198. MICHAELI DT, Stoycheva S, Marcus SM, Zhang W, et al
    Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa.
    Clin Drug Investig. 2022;42:333-343.
    PubMed    
    Abstract available

  199. BALASUBRAMANIAM SD, Balakrishnan V, Oon CE, Kaur G, et al
    Gene expression profiling of HPV-associated cervical carcinogenesis in formalin-fixed paraffin-embedded (FFPE) tissues using the NanoString nCounter(TM) platform.
    Gene. 2022;825:146385.
    PubMed    
    Abstract available

  200. ECHE MT, Vermaak K
    Knowledge, attitude and practice of female university students regarding human papillomavirus and self-sampling in KwaZulu-Natal, South Africa: a cross-sectional survey.
    BMC Womens Health. 2022;22:58.
    PubMed    
    Abstract available

  201. PHILLIPS S, Cassells K, Garland SM, Machalek DA, et al
    Gene methylation of CADM1 and MAL identified as a biomarker of high grade anal intraepithelial neoplasia.
    Sci Rep. 2022;12:3565.
    PubMed    
    Abstract available

  202. KARAFILLAKIS E, Peretti-Watel P, Verger P, Chantler T, et al
    "We don't have the same bodies; we don't react the same way": mothers and adolescent girls' perceptions of the risks and benefits of HPV vaccination in France.
    Hum Vaccin Immunother. 2022;18:2036555.
    PubMed    
    Abstract available

  203. BIYAZIN T, Yilma A, Yetwale A, Fenta B, et al
    Knowledge and attitude about human papillomavirus vaccine among female high school students at Jimma town, Ethiopia.
    Hum Vaccin Immunother. 2022;18:2036522.
    PubMed    
    Abstract available

  204. KOSTER S, Gurumurthy RK, Kumar N, Prakash PG, et al
    Modelling Chlamydia and HPV co-infection in patient-derived ectocervix organoids reveals distinct cellular reprogramming.
    Nat Commun. 2022;13:1030.
    PubMed    
    Abstract available

  205. KIM HW, Lee EJ, Lee YJ, Kim SY, et al
    Knowledge, attitudes, and perceptions associated with HPV vaccination among female Korean and Chinese university students.
    BMC Womens Health. 2022;22:51.
    PubMed    
    Abstract available


  206. Abnormal Pap Test Results.
    J Midwifery Womens Health. 2022;67:283-284.
    PubMed    


  207. DONG Z, Chang X, Xie L, Wang Y, et al
    Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma.
    Bioengineered. 2022;13:6100-6112.
    PubMed    
    Abstract available

  208. OLUBODUN T, Balogun MR, Odeyemi KA, Osibogun A, et al
    Effect of social marketing on the knowledge, attitude, and uptake of pap smear among women residing in an urban slum in Lagos, Nigeria.
    BMC Womens Health. 2022;22:42.
    PubMed    
    Abstract available

  209. HE W, Sparen P, Fang F, Sengpiel V, et al
    Pregnancy Outcomes in Women With a Prior Cervical Intraepithelial Neoplasia Grade 3 Diagnosis : A Nationwide Population-Based Cohort Study With Sibling Comparison Design.
    Ann Intern Med. 2022;175:210-218.
    PubMed    
    Abstract available

  210. PERKINS RB, Werner C, Wentzensen N
    What Contributes to Pregnancy Complications Among Women With Cervical Intraepithelial Neoplasia Grade 3?
    Ann Intern Med. 2022;175:293-294.
    PubMed    


  211. BITTLESTON H, Goller JL, Temple-Smith M, Hocking JS, et al
    ‘I didn’t want to visit a doctor unless it was extremely necessary’: perspectives on delaying access to sexual and reproductive health care during the COVID-19 pandemic in Australia from an online survey.
    Aust J Prim Health. 2022;28:131-136.
    PubMed    
    Abstract available

  212. KUROSAWA M, Sekine M, Yamaguchi M, Kudo R, et al
    Long-term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real-world data.
    Cancer Sci. 2022;113:1435-1440.
    PubMed    
    Abstract available

  213. ITO Y, Takasawa A, Takasawa K, Murakami T, et al
    Aberrant expression of claudin-6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma.
    Cancer Sci. 2022;113:1519-1530.
    PubMed    
    Abstract available

  214. ZHOU Q, Gong Y, Qiu X, Sui L, et al
    Visual appearance of the uterine cervix differs on the basis of HPV type status in high-grade squamous intraepithelial lesion: the results of a reliable method.
    BMC Womens Health. 2022;22:24.
    PubMed    
    Abstract available

  215. LIU L, Liu F, Liu D, Yuan W, et al
    A Smart Theranostic Prodrug System Activated by Reactive Oxygen Species for Regional Chemotherapy of Metastatic Cancer.
    Angew Chem Int Ed Engl. 2022;61:e202116807.
    PubMed    
    Abstract available

  216. ONUKI M, Yamamoto K, Yahata H, Kanao H, et al
    Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women.
    Cancer Sci. 2022;113:1428-1434.
    PubMed    
    Abstract available

  217. BAI A, Wang J, Li Q, Seery S, et al
    Assessing colposcopic accuracy for high-grade squamous intraepithelial lesion detection: a retrospective, cohort study.
    BMC Womens Health. 2022;22:9.
    PubMed    
    Abstract available

  218. ZHANG J, Nazeri SA, Sohrabi A
    Lead (Pb) exposure from outdoor air pollution: a potential risk factor for cervical intraepithelial neoplasia related to HPV genotypes.
    Environ Sci Pollut Res Int. 2022;29:26969-26976.
    PubMed    
    Abstract available

  219. CORIELL P, Engledow K, Roy S, Smith G, et al
    Delayed Hematogenous Metastasis Versus Second Primary Squamous Cell Carcinoma of the Neck in a Patient With Previous Cancer of the Cervix.
    Am Surg. 2022;88:989-991.
    PubMed    
    Abstract available

  220. HAAS JS, Cheng D, Yu L, Atlas SJ, et al
    Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics.
    Prev Med. 2022;154:106871.
    PubMed    
    Abstract available

  221. WANG F, Jozkowski KN, Zhang S
    Evaluating Risk-Stratified HPV Catch-up Vaccination Strategies: Should We Go beyond Age 26?
    Med Decis Making. 2022;42:524-537.
    PubMed    
    Abstract available

  222. MARLOW LAV, Nemec M, Vlaev I, Waller J, et al
    Testing the content for a targeted age-relevant intervention to promote cervical screening uptake in women aged 50-64 years.
    Br J Health Psychol. 2022;27:623-644.
    PubMed    
    Abstract available

  223. SCHOENAKER DAJM, Stephenson J, Connolly A, Shillaker S, et al
    Characterising and monitoring preconception health in England: a review of national population-level indicators and core data sources.
    J Dev Orig Health Dis. 2022;13:137-150.
    PubMed    
    Abstract available

  224. GUO M, Liang L, Wu L, Xie D, et al
    Application Value of Real-Time Ultrasonic Elastograph with Serum Human Epididymis Protein 4, Interleukin-33, and Carbohydrate Antigen 153 in Diagnosis of Early Cervical Cancer.
    J Healthc Eng. 2022;2022:4880874.
    PubMed    
    Abstract available

  225. HAUSIKU L, Kouame K, Aboua YG
    Perceptions and attitude of women of Luderitz, Namibia on Pap smear and cervical cancer prevention.
    BMC Womens Health. 2022;22:126.
    PubMed    
    Abstract available

  226. TANAKA T, Ueda S, Miyamoto S, Hashida S, et al
    Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer.
    Curr Oncol. 2022;29:2272-2283.
    PubMed    
    Abstract available

  227. FU Q, Li W, Zuo J, Yang X, et al
    A feasibility study of a modified treatment strategy combined external beam radiation therapy and brachytherapy for cervical cancer.
    J Appl Clin Med Phys. 2022 Apr 21:e13621. doi: 10.1002/acm2.13621.
    PubMed    
    Abstract available

  228. LYNCH J, D'Alton P, Gaynor K
    Evaluating the role of perceived injustice in mental health outcomes in cervical cancer care.
    Support Care Cancer. 2022 Apr 21. pii: 10.1007/s00520-022-07060.
    PubMed    
    Abstract available

  229. RAO D, Wang B, Zhong H, Yan Y, et al
    Construction of boric acid functionalized metal organic frameworks for glycopeptides recognition in the serum of cervical cancer patient.
    Rapid Commun Mass Spectrom. 2022 Apr 20:e9314. doi: 10.1002/rcm.9314.
    PubMed    
    Abstract available

  230. ORIGONI M, Cantatore F, Candotti G, Candiani M, et al
    Prognostic Significance of Neutrophil/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia.
    Biomed Res Int. 2022;2022:1149789.
    PubMed    
    Abstract available

  231. KURNIA I, Rauf S, Hatta M, Arifuddin S, et al
    Molecular Patho-mechanisms of cervical cancer (MMP1).
    Ann Med Surg (Lond). 2022;77:103415.
    PubMed    
    Abstract available

  232. ZHOU J, Wang Y, Zhang L, Chen Q, et al
    Engineered Exosomes-Mediated Transfer of hsa-miR-320a Overcomes Chemoresistance in Cervical Cancer Cells via Targeting MCL1.
    Front Pharmacol. 2022;13:883445.
    PubMed    
    Abstract available

  233. HORIKAWA N, Horie A, Kawahara S, Sunada M, et al
    Feasibility of Laparoscopic Para-Aortic Lymphadenectomy for Locally Advanced Cervical Cancer.
    JSLS. 2022;26.
    PubMed    
    Abstract available

  234. SHIMA E, Itsukaichi M, Yoshihara K, Ishiguro T, et al
    Fetal biometric and Doppler measurements following abdominal radical trachelectomy in the second trimester of the pregnancy.
    BMC Pregnancy Childbirth. 2022;22:343.
    PubMed    
    Abstract available

  235. XU Y, Sun Y, Chang H, Cai J, et al
    The Expression of HPV E6/E7 mRNAIn SituHybridization in HPV Typing-negative Cervical Cancer.
    Int J Gynecol Pathol. 2022 Apr 12. pii: 00004347-990000000-00012.
    PubMed    
    Abstract available

  236. GOMEZ-HIDALGO NR, Acosta U, Rodriguez TG, Mico S, et al
    Adjuvant therapy in early-stage cervical cancer after radical hysterectomy: are we overtreating our patients? A meta-analysis.
    Clin Transl Oncol. 2022 Apr 19. pii: 10.1007/s12094-022-02808.
    PubMed    
    Abstract available

  237. DENG T, Gu S, Wu J, Yu Y, et al
    Comparison of platinum monotherapy with concurrent chemoradiation therapy versus platinum-based dual drug therapy with concurrent chemoradiation therapy for locally advanced cervical cancer: a systematic review and meta-analysis.
    Infect Agent Cancer. 2022;17:18.
    PubMed    
    Abstract available

  238. ZHANG J, Buranjiang G, Mutalifu Z, Jin H, et al
    KIF14 affects cell cycle arrest and cell viability in cervical cancer by regulating the p27(Kip1) pathway.
    World J Surg Oncol. 2022;20:125.
    PubMed    
    Abstract available

  239. VICTORELLI FD, Salvati Manni L, Biffi S, Bortot B, et al
    Potential of curcumin-loaded cubosomes for topical treatment of cervical cancer.
    J Colloid Interface Sci. 2022;620:419-430.
    PubMed    
    Abstract available

  240. TORREGLOSA-HERNANDEZ S, Grisales-Romero H, Morales-Carmona E, Hernandez-Avila JE, et al

    Salud Publica Mex. 2022;64:76-86.
    PubMed    
    Abstract available

  241. MILLER J, Dakic A, Spurgeon M, Saenz F, et al
    AIB1 Is A Novel Target of the High-Risk HPV E6 protein and A Biomarker of Cervical Cancer Progression.
    J Med Virol. 2022 Apr 18. doi: 10.1002/jmv.27795.
    PubMed    
    Abstract available

  242. CHOI Y, Ibrahim S, Park LP, Cohen CR, et al
    Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
    BMC Womens Health. 2022;22:122.
    PubMed    
    Abstract available

  243. ZHOU L, Gu B, Wang J, Liu G, et al
    Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model.
    BMC Public Health. 2022;22:777.
    PubMed    
    Abstract available

  244. LIU X, Wang Z, Wang L, Wang Y, et al
    Signature involved in immune-related lncRNA pairs for predicting the immune landscape of cervical cancer.
    Int J Biol Markers. 2022 Apr 18:3936155221091832. doi: 10.1177/03936155221091832
    PubMed    
    Abstract available

  245. NARAYAN R, Rana F, Jakka S, Prasad A, et al
    Intestinal metastasis from carcinoma cervix: An (un) common occurrence in a common cancer. A series of five cases from a single institution.
    Indian J Pathol Microbiol. 2022;65:396-400.
    PubMed    
    Abstract available

  246. DEODHAR KK, Banerjee D, Rekhi B, Menon S, et al
    Study of histopathology reports of loop electrosurgical excision procedure of cervical transformation zone and their correlation with preprocedural cervical biopsy and/or cytology: An audit.
    Indian J Pathol Microbiol. 2022;65:392-395.
    PubMed    
    Abstract available

  247. JI H, Hu N
    Circular RNA 0001823 aggravates the growth and metastasis of the cervical cancer cells through modulating the microRNA-613/RAB8A axis.
    Bioengineered. 2022;13:10335-10349.
    PubMed    
    Abstract available

  248. MARQUES P, Geraldes M, Gama A, Heleno B, et al
    Non-attendance in cervical cancer screening among migrant women in Portugal: A cross-sectional study.
    Womens Health (Lond). 2022;18:17455057221093034.
    PubMed    
    Abstract available

  249. GLASSMAN D, Patel JM, Hathout L, Thomas S, et al
    Benign metastasizing leiomyoma in retroperitoneal lymph nodes with concurrent early stage cervical cancer.
    Gynecol Oncol Rep. 2022;40:100975.
    PubMed    
    Abstract available

  250. WANG LN, Huang KJ, Wang L, Cheng HY, et al
    Overexpression of Ubiquilin4 is associated with poor prognosis in patients with cervical cancer.
    World J Clin Cases. 2022;10:2783-2791.
    PubMed    
    Abstract available

  251. MA X, Gao Y, Wang J, Wu Z, et al
    Efficacy of Transversus Abdominis Plane Block in Patients After Laparoscopic Radical Cervical Cancer Surgery.
    Front Surg. 2022;9:674987.
    PubMed    
    Abstract available

  252. XU M, Xie X, Cai L, Xie Y, et al
    Risk Factor Assessment of Lymph Node Metastasis in Patients With FIGO Stage IB1 Cervical Cancer.
    Front Oncol. 2022;12:809159.
    PubMed    
    Abstract available

  253. OMOYENI OM, Tsoka-Gwegweni JM
    Prevalence of cervical abnormalities among rural women in KwaZulu-Natal, South Africa.
    Pan Afr Med J. 2022;41:110.
    PubMed    
    Abstract available

  254. JIA H, Hao S, Cao M, Wang L, et al
    m(6)A-Related lncRNAs Are Potential Prognostic Biomarkers of Cervical Cancer and Affect Immune Infiltration.
    Dis Markers. 2022;2022:8700372.
    PubMed    
    Abstract available

  255. ZOU C, Xu F, Shen J, Xu S, et al
    Identification of a Ferroptosis-Related Prognostic Gene PTGS2 Based on Risk Modeling and Immune Microenvironment of Early-Stage Cervical Cancer.
    J Oncol. 2022;2022:3997562.
    PubMed    
    Abstract available

  256. JIANG Q, Wang L, Jin M, Shou Y, et al
    The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer.
    Int J Gen Med. 2022;15:3903-3914.
    PubMed    
    Abstract available

  257. ZHANG J, Yang X, Ni H
    Long non-coding RNA FLVCR1-AS1 functions as a ceRNA to aggravate cervical cancer cell growth by the miR-381-3p/MAGT1 axis.
    Arch Gynecol Obstet. 2022 Apr 16. pii: 10.1007/s00404-022-06468.
    PubMed    
    Abstract available

  258. MANZOUR N, Chiva L, Chacon E, Martin-Calvo N, et al
    SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer.
    Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11671.
    PubMed    
    Abstract available

  259. MINOCHA T, Das M, Rai V, Verma SS, et al
    Melatonin induces apoptosis and cell cycle arrest in cervical cancer cells via inhibition of NF-kappaB pathway.
    Inflammopharmacology. 2022 Apr 17. pii: 10.1007/s10787-022-00964.
    PubMed    
    Abstract available

  260. LI Q, Zhu M, Li Y, Tang H, et al
    Estrone-targeted PEGylated Liposomal Nanoparticles for Cisplatin (DDP) Delivery in Cervical Cancer.
    Eur J Pharm Sci. 2022 Apr 14:106187. doi: 10.1016/j.ejps.2022.106187.
    PubMed    
    Abstract available

  261. KALJOUW S, Jansen EEL, Aitken CA, de Kok IMCM, et al
    Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: A modelling study.
    BJOG. 2022 Apr 16. doi: 10.1111/1471-0528.17190.
    PubMed    
    Abstract available

  262. WANG D, Liu Y, Cheng S, Liu G, et al
    Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods.
    Med Sci Monit. 2022;28:e934799.
    PubMed    
    Abstract available

  263. FISHER L
    Retraction: RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells via the posttranscriptional suppression of HGFR.
    RSC Adv. 2021;11:5230.
    PubMed    
    Abstract available

  264. FISHER L
    Retraction: The nuclear export of TR3 mediated gambogic acid-induced apoptosis in cervical cancer cells through mitochondrial dysfunction.
    RSC Adv. 2021;11:4443.
    PubMed    
    Abstract available

  265. FISHER L
    Retraction: Down-regulation of the radiation-induced pEGFR(Thr654) mediated activation of DNA-PK by Cetuximab in cervical cancer cells.
    RSC Adv. 2021;11:5021.
    PubMed    
    Abstract available

  266. FISHER L
    Retraction: Long non-coding RNA NEAT1 accelerates cell progression in cervical cancer by regulating the miR-889-3p/E2F7 axis through the activation of the PI3K/AKT pathway.
    RSC Adv. 2021;11:5025.
    PubMed    
    Abstract available

  267. LIU W, Yao X, Ou X
    Incidental Diagnosis of Right Renal Subcapsular Urinoma on an 18F-FDG PET/CT Scan Performed for Staging of Cervical Cancer.
    Clin Nucl Med. 2022 Apr 15. pii: 00003072-990000000-00071.
    PubMed    
    Abstract available

  268. ADEGBOYEGA A, Aroh A, Williams LB, Mudd-Martin G, et al
    Social support and cervical cancer screening among sub-Saharan African immigrant (SAI) women.
    Cancer Causes Control. 2022 Apr 15. pii: 10.1007/s10552-022-01577.
    PubMed    
    Abstract available

  269. HUANG Y, Zhu Q, Xue L, Zhu X, et al
    Machine Learning-Assisted Ensemble Analysis for the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
    Front Oncol. 2022;12:817250.
    PubMed    
    Abstract available

  270. YU H, Zheng R, Lei F, Wang W, et al
    Antibody-conjugated silica-coated gold nanoparticles in targeted therapy of cervical cancer.
    Am J Transl Res. 2022;14:1518-1534.
    PubMed    
    Abstract available

  271. SARWAR A, Lalli N, Eminowicz G
    Ureter dose optimization during image guided brachytherapy for cervical cancer.
    Brachytherapy. 2022 Apr 11. pii: S1538-4721(22)00035.
    PubMed    
    Abstract available

  272. FRUND C, Kenfack B, Sormani J, Wisniak A, et al
    Training, Supervision, and Competence Assessment of Cameroonian Health Care Providers Using HPV Self-Sampling, Triage by Visual Inspection, and Treatment by Thermal Ablation in a Single Visit.
    Front Public Health. 2022;10:875177.
    PubMed    
    Abstract available

  273. ZHANG Y, Ding J, Zhang X, Hua K, et al
    Ubiquitin C-terminal hydrolase L1 promotes lymph node metastasis in small cell neuroendocrine carcinomas of the cervix.
    J Int Med Res. 2022;50:3000605221087620.
    PubMed    
    Abstract available

  274. TEJADA RA, Malagon T, Franco EL
    Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis.
    Vaccine. 2022 Mar 31. pii: S0264-410X(22)00357.
    PubMed    
    Abstract available

  275. GONG Y, Sui L, Li Y
    Recombination in Papillomavirus: Controversy and Possibility.
    Virus Res. 2022;314:198756.
    PubMed    
    Abstract available

  276. PARANA VC, Souza Santos D, Barreto de Souza Silva DI, Lima GC, et al
    Anal and cervical human papillomavirus genotypes in women co-infected with human immunodeficiency virus: A systematic review.
    Int J STD AIDS. 2022;33:530-543.
    PubMed    
    Abstract available

  277. WIELGOS A, Pietrzak B, Suchonska B, Sikora M, et al
    A Six-Year Gynecological Follow-Up of Immunosuppressed Women with a High-Risk Human Papillomavirus Infection.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  278. FENG D, Wei S, Chen J, Yu Z, et al
    Human papillomavirus prevalence and genotype distribution landscapes in Shannan City, Tibet Tibetan Autonomous Region, China.
    Virol J. 2022;19:46.
    PubMed    
    Abstract available

  279. KOMATSU M, Nakamura K, Takeda T, Chiwaki F, et al
    Aurora kinase blockade drives de novo addiction of cervical squamous cell carcinoma to druggable EGFR signalling.
    Oncogene. 2022;41:2326-2339.
    PubMed    
    Abstract available

  280. WONDIMU A, Postma MJ, van Hulst M
    Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia.
    Vaccine. 2022 Mar 2. pii: S0264-410X(22)00245.
    PubMed    
    Abstract available

  281. DENNY L
    HPV vaccine introduction and implementation in LMICs.
    Vaccine. 2022 Mar 1. pii: S0264-410X(22)00227.
    PubMed    


  282. PARK JY, Lee JY, Lee YY, Shim SH, et al
    Major clinical research advances in gynecologic cancer in 2021.
    J Gynecol Oncol. 2022;33:e43.
    PubMed    
    Abstract available

  283. CUI X, Hao C, Gong L, Kajitani N, et al
    HnRNP D activates production of HPV16 E1 and E6 mRNAs by promoting intron retention.
    Nucleic Acids Res. 2022;50:2782-2806.
    PubMed    
    Abstract available

  284. DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
    Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United Kingdom.
    Vaccine. 2022 Feb 26. pii: S0264-410X(22)00220.
    PubMed    
    Abstract available

  285. OUANHNON L, Rouge Bugat ME, Lamy S, Druel V, et al
    Social and territorial inequalities in breast and cervical cancers screening uptake: a cross-sectional study in France.
    BMJ Open. 2022;12:e055363.
    PubMed    
    Abstract available

  286. LEE GY, Inthasorn P, Laowahutanont P, Lawpoolsri S, et al
    Long-term effectiveness of human papillomavirus vaccines among adult women: A real-world scenario.
    Vaccine. 2022 Feb 18. pii: S0264-410X(22)00188.
    PubMed    
    Abstract available

  287. HIDLE A, Brennan T, Garon J, An Q, et al
    Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohorts.
    Vaccine. 2022 Feb 15. pii: S0264-410X(22)00047.
    PubMed    
    Abstract available

  288. MA Y, Li WY, Sun T, Zhang L, et al
    Structure-based discovery of a specific SHP2 inhibitor with enhanced blood-brain barrier penetration from PubChem database.
    Bioorg Chem. 2022;121:105648.
    PubMed    
    Abstract available

  289. BROTHERTON JM, Hawkes D, Saville M
    Reasons for rejection of self-collected samples for cervical screening.
    Med J Aust. 2022;216:214.
    PubMed    


  290. MACHALEK D, Rees H, Chikandiwa A, Munthali R, et al
    Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before-after design.
    BMJ Open. 2022;12:e059968.
    PubMed    
    Abstract available

  291. HU Q, Shi J, Zhang A, Duan S, et al
    Added value of radiomics analysis in MRI invisible early-stage cervical cancers.
    Br J Radiol. 2022 Feb 10:20210986. doi: 10.1259/bjr.20210986.
    PubMed    
    Abstract available

  292. SUN F, Jie Q, Li Q, Wei Y, et al
    TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway.
    J Cell Mol Med. 2022;26:1629-1642.
    PubMed    
    Abstract available

  293. MAC EOCHAGAIN C, Power R, Parker I, Brennan D, et al
    HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis.
    J Gynecol Oncol. 2022;33:e24.
    PubMed    
    Abstract available

  294. NNAJI CA, Ezenwankwo EF, Kuodi P, Walter FM, et al
    Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review.
    BMJ Open. 2022;12:e057685.
    PubMed    
    Abstract available

  295. MORGAN C, Giattas MR, Holroyd T, Pfitzer A, et al
    Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidence.
    Vaccine. 2022 Jan 29. pii: S0264-410X(21)01674.
    PubMed    
    Abstract available

  296. CATALFAMO CJ, Brown HE, Dennis LK
    Evaluating the Strength of Association of Human Papillomavirus Infection With Penile Carcinoma: A Meta-Analysis.
    Sex Transm Dis. 2022;49:368-376.
    PubMed    
    Abstract available

  297. YE M, Li S, Luo P, Tang X, et al
    Genetic variation of E6, E7, and L1 genes of human papillomavirus 51 from central China.
    J Med Virol. 2022;94:2811-2823.
    PubMed    
    Abstract available

  298. ZHANG YY, Xia R, Chen D, Zhang X, et al
    Analysis of related factors of cervical intraepithelial neoplasia complicated with vaginal intraepithelial neoplasia.
    Clin Transl Oncol. 2022;24:902-908.
    PubMed    
    Abstract available

  299. ZHANG S, Wang H, Liu Y, Tao T, et al
    Nocardia rubra cell-wall skeleton influences the development of cervical carcinoma by promoting the antitumor effect of macrophages and dendritic cells.
    Cancer Med. 2022;11:1249-1268.
    PubMed    
    Abstract available

  300. MA M, Zhu J, Yang Y, Wang X, et al
    The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions.
    Cancer Med. 2022;11:1542-1552.
    PubMed    
    Abstract available

  301. ALLANSON ER, Phoolcharoen N, Salcedo MP, Fellman B, et al
    Accuracy of Smartphone Images of the Cervix After Acetic Acid Application for Diagnosing Cervical Intraepithelial Neoplasia Grade 2 or Greater in Women With Positive Cervical Screening: A Systematic Review and Meta-Analysis.
    JCO Glob Oncol. 2021;7:1711-1721.
    PubMed    
    Abstract available

  302. IKESU R, Taguchi A, Hara K, Kawana K, et al
    Prognosis of high-risk human papillomavirus-related cervical lesions: A hidden Markov model analysis of a single-center cohort in Japan.
    Cancer Med. 2022;11:664-675.
    PubMed    
    Abstract available

  303. KONDO E, Yoshida K, Tabata T, Kobayashi Y, et al
    Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study.
    J Gynecol Oncol. 2022;33:e14.
    PubMed    
    Abstract available

  304. TOGAMI S, Ushiwaka T, Kitazono I, Yanazume S, et al
    One-step nucleic acid amplification (OSNA) assay for detecting lymph node metastasis in cervical and endometrial cancer: a preliminary study.
    J Gynecol Oncol. 2022;33:e11.
    PubMed    
    Abstract available

  305. HAN X, Song G, Li Y, Dong Z, et al
    Prevalence and genotype distribution of human papillomavirus infection among women aged 30-65 years in Xi'an, China: a population-based study of 14,655 women.
    Hum Vaccin Immunother. 2021;17:5439-5446.
    PubMed    
    Abstract available

  306. SHI Z, Lin J, Wu Y, Fu S, et al
    Burden of cancer and changing cancer spectrum among older adults in China: Trends and projections to 2030.
    Cancer Epidemiol. 2022;76:102068.
    PubMed    
    Abstract available

  307. WEI X, Lu Q, Wang S
    Prevalence characteristics of cervical human papillomavirus genotypes in Nanning, China: A 10-year survey of 77,756 women from one medical center.
    J Med Virol. 2022;94:2787-2795.
    PubMed    
    Abstract available

  308. ENGEL D, Afeli ADJ, Morgan C, Zeck W, et al
    Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo.
    Vaccine. 2021 Nov 26. pii: S0264-410X(21)01466.
    PubMed    
    Abstract available

  309. HIRAMATSU K, Ueda Y, Yagi A, Morimoto A, et al
    The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study.
    Hum Vaccin Immunother. 2022;18:1951098.
    PubMed    
    Abstract available

  310. ANASTASIOU E, McCarthy KJ, Gollub EL, Ralph L, et al
    The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: a systematic review.
    Contraception. 2021 Nov 6. pii: S0010-7824(21)00445.
    PubMed    
    Abstract available

  311. FACHETTI-MACHADO G, Figueiredo-Alves RR, Moreira MAR
    Performance of three colposcopic images for the identification of squamous and glandular cervical precursor neoplasias.
    Arch Gynecol Obstet. 2022;305:1319-1327.
    PubMed    
    Abstract available

  312. MCMULLEN-TABRY ER, Sciallis AP, Skala SL
    Surface prostatic metaplasia, transitional cell metaplasia and superficial clusters of small basophilic cells in the uterine cervix: prevalence in gender-affirming hysterectomies and comparison with benign hysterectomies from cisgender women.
    Histopathology. 2022;80:946-953.
    PubMed    
    Abstract available

  313. SINNO N, Taylor E, Milosevic M, Jaffray DA, et al
    Incorporating cross-voxel exchange into the analysis of dynamic contrast-enhanced imaging data: theory, simulations and experimental results.
    Phys Med Biol. 2021;66.
    PubMed    
    Abstract available

  314. DA SILVA BEB, de Lemos LMD, de Aragao Batista MV, Lima CA, et al
    Prevalence of human papillomavirus infection in Brazilian women living with HIV: a systematic review and meta-analysis.
    Expert Rev Anti Infect Ther. 2022;20:611-620.
    PubMed    
    Abstract available

  315. CASEY RM, Adrien N, Badiane O, Diallo A, et al
    National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
    Vaccine. 2021 Sep 27. pii: S0264-410X(21)01075.
    PubMed    
    Abstract available

  316. MA J, Zhang X, Wang W, Zhang R, et al
    Knowledge of HPV, its vaccines, and attitudes toward HPV vaccines among obstetrician-gynecologists, pediatricians and immunization services providers in Western China.
    Hum Vaccin Immunother. 2022;18:1-7.
    PubMed    
    Abstract available

  317. AHMED D, VanderEnde K, Harvey P, Bhatnagar P, et al
    Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019.
    Vaccine. 2021 Aug 21. pii: S0264-410X(21)00901.
    PubMed    
    Abstract available

  318. HAUSI H, Nicks P, Mzengeza T, Tsega A, et al
    The challenge of identifying eligible girls for HPV vaccination: HPV mapping data verification in Malawi.
    Vaccine. 2021 Aug 20. pii: S0264-410X(21)00902.
    PubMed    
    Abstract available

  319. JONES A, Kawesa-Newell N
    Using branded behaviour change communication to create demand for the HPV vaccine among girls in Malawi: An evaluation of Girl Effect's Zathu mini magazine.
    Vaccine. 2021 Jul 30. pii: S0264-410X(21)00870.
    PubMed    
    Abstract available

  320. CHEN T, Liu X, Feng R, Wang W, et al
    Discriminative Cervical Lesion Detection in Colposcopic Images With Global Class Activation and Local Bin Excitation.
    IEEE J Biomed Health Inform. 2022;26:1411-1421.
    PubMed    
    Abstract available

  321. VODICKA E, Nonvignon J, Antwi-Agyei KO, Bawa J, et al
    The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana.
    Vaccine. 2021 Jul 21. pii: S0264-410X(21)00904.
    PubMed    
    Abstract available

  322. AISAGBONHI O, Zare SY, Hasteh F, Binder P, et al
    PTEN Loss and ARID1A Mutation in an HPV-positive Metastatic Adenocarcinoma Diagnosed Almost 18 yr After an Intact Cone Excision for Endocervical Adenocarcinoma In Situ.
    Int J Gynecol Pathol. 2022;41:307-312.
    PubMed    
    Abstract available

  323. LAMONTAGNE DS, Manangazira P, Marembo J, Chigodo C, et al
    HPV vaccination coverage in three districts in ZIMBABWE following national introduction of 0,12 month schedule among 10 to 14 year old girls.
    Vaccine. 2021 Jul 15. pii: S0264-410X(21)00871.
    PubMed    
    Abstract available

  324. KOC S, Yuksel D, Kayikcioglu F
    Colposcopic histopathology results of patients over 50: Is HPV genotyping useful?
    Curr Probl Cancer. 2022;46:100764.
    PubMed    
    Abstract available

  325. LI AJ, Manzi F, Kyesi F, Makame Y, et al
    Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
    Vaccine. 2021 Jul 3. pii: S0264-410X(21)00797.
    PubMed    
    Abstract available

  326. RODRIGUES CF, Coutinho JVA, Muzi CD, Guimaraes RM, et al
    Reasons for never receiving a pap test among Brazilian women: National health survey.
    Public Health Nurs. 2021;38:963-977.
    PubMed    
    Abstract available

  327. GARON JR, Mukavhi A, Rupfutse M, Bright S, et al
    Multiple cohort HPV vaccination in Zimbabwe: 2018-2019 program feasibility, awareness, and acceptability among health, education, and community stakeholders.
    Vaccine. 2021 Jun 15. pii: S0264-410X(21)00669.
    PubMed    
    Abstract available

  328. HOES J, Pasmans H, Schurink-van 't Klooster TM, van der Klis FRM, et al
    Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge.
    Hum Vaccin Immunother. 2022;18:1908059.
    PubMed    
    Abstract available

  329. HELLSTEN C, Ernstson A, Bodelsson G, Forslund O, et al
    Equal prevalence of severe cervical dysplasia by HPV self-sampling and by midwife-collected samples for primary HPV screening: a randomised controlled trial.
    Eur J Cancer Prev. 2021;30:334-340.
    PubMed    
    Abstract available

  330. SHADAB R, Lavery JV, McFadden SM, Elharake JA, et al
    Key ethical considerations to guide the adjudication of a single-dose HPV vaccine schedule.
    Hum Vaccin Immunother. 2022;18:1917231.
    PubMed    
    Abstract available

  331. MPHURU A, Li AJ, Kyesi F, Mwengee W, et al
    National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00472.
    PubMed    
    Abstract available

  332. LI AJ, Kyesi F, Mwengee W, Mphuru A, et al
    Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania's national HPV vaccine introduction.
    Vaccine. 2021 Jan 25. pii: S0264-410X(21)00052.
    PubMed    


  333. TELVIZIAN T, Al Ghadban Y, Alawa J, Mukherji D, et al
    Knowledge, beliefs, and practices related to cancer screening and prevention in Lebanon: community and social media users' perspectives.
    Eur J Cancer Prev. 2021;30:341-349.
    PubMed    
    Abstract available

  334. PARTANEN VM, Heinavaara S, Anttila A, Hakkarainen J, et al
    Setting the record straight-Correcting uterine cancer incidence and mortality in the Nordic countries by reallocation of unspecified cases.
    Acta Obstet Gynecol Scand. 2022 Jan 18. doi: 10.1111/aogs.14314.
    PubMed    
    Abstract available

  335. BORGFELDT C, Leksell A, Forslund O
    Co-testing in cervical screening among 40- to 42-year-old women is unreasonable.
    Acta Obstet Gynecol Scand. 2022;101:374-378.
    PubMed    
    Abstract available

  336. FEINBERG J, Hodgson A, Abu-Rustum NR, Long Roche K, et al
    Clinical, Morphologic, and Molecular Features Associated With Ovarian Metastases From Pattern A Endocervical Adenocarcinomas.
    Am J Surg Pathol. 2021 Dec 10. pii: 00000478-900000000-97090.
    PubMed    
    Abstract available

  337. KIYOKAWA T, Hoang L, Pesci A, Alvarado-Cabrero I, et al
    Claudin-18 as a Promising Surrogate Marker for Endocervical Gastric-type Carcinoma.
    Am J Surg Pathol. 2022;46:628-636.
    PubMed    
    Abstract available

  338. WANG Y, Chang RJ, Luo RZ, Yu J, et al
    Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study.
    Am J Surg Pathol. 2022;46:713-724.
    PubMed    
    Abstract available

  339. REGAUER S, Reich O, Kashofer K
    Cervical Precancers Originate From Infected Proliferating Reserve Cells: A Comparative Histologic and Genetic Study of Thin and Thick High-grade Squamous Intraepithelial Lesions.
    Am J Surg Pathol. 2022;46:519-527.
    PubMed    
    Abstract available

  340. ROCKALL AG, Barwick TD, Wilson W, Singh N, et al
    DIAGNOSTIC ACCURACY OF FEC-PET/CT, FDG-PET/CT AND DIFFUSION-WEIGHTED MRI IN DETECTION OF NODAL METASTASES IN SURGICALLY TREATED ENDOMETRIAL AND CERVICAL CARCINOMA.
    Clin Cancer Res. 2021 Sep 15. pii: 1078-0432.CCR-21-1834.
    PubMed    
    Abstract available

  341. SENTHIL KUMAR D, Ravikumar G
    Quality metrics in cervical cytopathology: A single institutional study.
    Cytopathology. 2022;33:230-235.
    PubMed    
    Abstract available

  342. GUPTA P, Gupta N, Dey P, Bagga R, et al
    Cervical cytology in the detection of uterine clear cell carcinoma: Diagnostic predictors from a case-control study.
    Cytopathology. 2022;33:236-248.
    PubMed    
    Abstract available

  343. BURGESS H, Ellis K, Gillespie AM, Macdonald MC, et al
    Invasive cervical cancer audit: what lessons can we learn locally and where would we stand with regard to Duty of Candour?
    Cytopathology. 2022 Apr 13. doi: 10.1111/cyt.13128.
    PubMed    
    Abstract available

  344. LEESON S, Evered A, Powell G, Lilly K, et al
    Early Welsh cervical screening programme learning as a consequence of the coronavirus pandemic.
    Cytopathology. 2022;33:350-356.
    PubMed    
    Abstract available

  345. TOYODA S, Sado T, Ito F, Taniguchi M, et al
    Unusual uterine cervical polypoid mass presenting during pregnancy.
    Cytopathology. 2022;33:409-411.
    PubMed    
    Abstract available

  346. NERSESYAN A, Parsadanyan G
    Re: "Cytomorphometry and morphology analysis of human papillomavirus type 16 in liquid-based cervical cytology samples" by Safi Oz et al.
    Diagn Cytopathol. 2022;50:263-264.
    PubMed    


  347. KHEBBEB S, Rathat G, Serrand C, Bourdon A, et al
    Interest of para-aortic lymphadenectomy for locally advanced cervical cancer in the era of PET scanning.
    Eur J Obstet Gynecol Reprod Biol. 2022;272:234-239.
    PubMed    
    Abstract available

  348. MOHAMUD A, Hogdall C, Schnack T
    Prognostic value of the 2018 FIGO staging system for cervical cancer.
    Gynecol Oncol. 2022 Mar 25. pii: S0090-8258(22)00127.
    PubMed    
    Abstract available

  349. SAPIENZA LG, Thomas JJ, Showalter TN, Echeverria AE, et al
    Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal.
    Gynecol Oncol. 2022 Apr 8. pii: S0090-8258(22)00208.
    PubMed    
    Abstract available

  350. BARRINGTON DA, Riedinger C, Haight PJ, Tubbs C, et al
    Pembrolizumab with or without bevacizumab for recurrent or metastatic cervical cancer: A cost-effectiveness analysis.
    Gynecol Oncol. 2022 Apr 11. pii: S0090-8258(22)00213.
    PubMed    
    Abstract available

  351. SAHASRABUDDHE VV, Castle PE, Schiffman M, Wentzensen N, et al
    Reply to: Comments on 'Meta-analysis of agreement/concordance statistics in studies comparing self- versus clinician-collected samples for HPV testing in cervical cancer screening'.
    Int J Cancer. 2022 Apr 4. doi: 10.1002/ijc.34013.
    PubMed    


  352. BRENTNALL AR, Rebolj M
    Comments on: "Meta-analysis of agreement/concordance statistics in studies comparing self-versus clinician-collected samples for HPV testing in cervical cancer screening".
    Int J Cancer. 2022 Apr 4. doi: 10.1002/ijc.34014.
    PubMed    


  353. LEE J, Lin JB, Chang CL, Jan YT, et al
    Optimal prophylactic para-aortic radiotherapy in locally advanced cervical cancer: anatomy-based versus margin-based delineation.
    Int J Gynecol Cancer. 2022 Mar 30. pii: ijgc-2021-003298.
    PubMed    
    Abstract available


  354. Correction: Human papillomavirus-independent cervical cancer: what are the implications?
    Int J Gynecol Cancer. 2022;32:582.
    PubMed    


  355. GLENNON K, Treacy A, Geoghegan T, Downey P, et al
    Endocervical adenocarcinoma in situ with ovarian metastases.
    Int J Gynecol Cancer. 2022;32:566-569.
    PubMed    


  356. ANGELES MA, Bizzarri N, Shushkevich A, Gomez-Hidalgo NR, et al
    Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilation.
    Int J Gynecol Cancer. 2022;32:468-473.
    PubMed    


  357. AGUSTI N, Zorrilla Vaca A, Segarra-Vidal B, Iniesta MD, et al
    Outcomes of open radical hysterectomy following implementation of an enhanced recovery after surgery program.
    Int J Gynecol Cancer. 2022;32:480-485.
    PubMed    
    Abstract available

  358. GARCIA-DURAN C, Grau F, Villacampa G, Oaknin A, et al
    ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation.
    Int J Gynecol Cancer. 2022 Apr 20. pii: ijgc-2022-003370.
    PubMed    
    Abstract available

  359. KOTHA NV, Williamson CW, Mell LK, Murphy JD, et al
    Disparities in time to start of definitive radiation treatment for patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2022 Apr 15. pii: ijgc-2021-003305.
    PubMed    
    Abstract available

  360. TOBONI MD, Cohen A, Gentry ZL, Ostby SA, et al
    Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.
    Int J Gynecol Cancer. 2022 Apr 15. pii: ijgc-2021-003227.
    PubMed    
    Abstract available

  361. FENLON JB, Rositch AF, Dickey BL, Kimani S, et al
    Gynecological radiotherapy in people living with human immunodeficiency virus: a semi-systematic literature review.
    Int J Gynecol Cancer. 2022;32:429-435.
    PubMed    
    Abstract available

  362. BHATIA R, Lichter KE, Gurram L, MacDuffie E, et al
    The state of gynecologic radiation therapy in low- and middle-income countries.
    Int J Gynecol Cancer. 2022;32:421-428.
    PubMed    
    Abstract available

  363. ZHOU Y, Espenel S, Achkar S, Leary A, et al
    Combined modality including novel sensitizers in gynecological cancers.
    Int J Gynecol Cancer. 2022;32:389-401.
    PubMed    
    Abstract available

  364. DONOVAN EK, Covens AL, Kupets RS, Leung EW, et al
    The role of oophoropexy in patients with gynecological cancer who need radiation therapy.
    Int J Gynecol Cancer. 2022;32:380-388.
    PubMed    
    Abstract available

  365. KIDD EA
    Imaging to optimize gynecological radiation oncology.
    Int J Gynecol Cancer. 2022;32:358-365.
    PubMed    
    Abstract available

  366. JHINGRAN A
    Updates in the treatment of vaginal cancer.
    Int J Gynecol Cancer. 2022;32:344-351.
    PubMed    
    Abstract available

  367. HSU IC, Yoshida E
    Ultrasound guidance for cervical implantation.
    Int J Gynecol Cancer. 2022;32:266-272.
    PubMed    
    Abstract available

  368. FRANCO I, Viswanathan AN
    Radiation oncology management of stage III and IVA cervical carcinoma.
    Int J Gynecol Cancer. 2022;32:231-238.
    PubMed    
    Abstract available

  369. CHOPRA S, Ranjan N, Mittal P
    Postoperative adjuvant radiation for cervix cancer: reflections on the evidence and a peep into the future.
    Int J Gynecol Cancer. 2022;32:225-230.
    PubMed    
    Abstract available

  370. XIAO W, Zhou S, Xu H, Li H, et al
    [Corrigendum] NogoB promotes the epithelialmesenchymal transition in HeLa cervical cancer cells via Fibulin5.
    Oncol Rep. 2022;47.
    PubMed    
    Abstract available

  371. HOLMQVIST A, Lindahl G, Mikivier R, Uppungunduri S, et al
    Age as a potential predictor of acute side effects during chemoradiotherapy in primary cervical cancer patients.
    BMC Cancer. 2022;22:371.
    PubMed    
    Abstract available

  372. CHEN L, Qing J, Xiao Y, Huang X, et al
    TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
    BMC Cancer. 2022;22:370.
    PubMed    
    Abstract available

  373. WANG H, Jiang Y, Liang Y, Wei L, et al
    Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia.
    BMC Cancer. 2022;22:362.
    PubMed    
    Abstract available

  374. PARK SJ, Kong TW, Kim T, Lee M, et al
    Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial prot
    BMC Cancer. 2022;22:331.
    PubMed    
    Abstract available

  375. WEI B, Zhang B, Xue P, Seery S, et al
    Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China.
    BMC Cancer. 2022;22:388.
    PubMed    
    Abstract available

  376. WU X, Feng H, Gao S, Feng H, et al
    A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial.
    BMC Cancer. 2022;22:384.
    PubMed    
    Abstract available

  377. LI K, Xu H, Wang S, Qin P, et al
    Disparities in the increases of cervical cancer incidence rates: observations from a city-wide population-based study.
    BMC Cancer. 2022;22:419.
    PubMed    
    Abstract available

  378. HE Y, Han SB, Liu Y, Zhang JJ, et al
    Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
    BMC Cancer. 2022;22:411.
    PubMed    
    Abstract available

  379. GALLARDO-ALVARADO L, Cantu-de Leon D, Ramirez-Morales R, Santiago-Concha G, et al
    Tumor histology is an independent prognostic factor in locally advanced cervical carcinoma: A retrospective study.
    BMC Cancer. 2022;22:401.
    PubMed    
    Abstract available

  380. PHAIPHICHIT J, Paboriboune P, Kunnavong S, Chanthavilay P, et al
    Factors associated with cervical cancer screening among women aged 25-60 years in Lao People's Democratic Republic.
    PLoS One. 2022;17:e0266592.
    PubMed    
    Abstract available

  381. SAKAMOTO J, Saito M, Zhang S, Takakura M, et al
    Determination of human papillomavirus type in archival tissue specimens of invasive cervical cancer using molecular mapping and E6/E7-based polymerase chain reaction.
    PLoS One. 2022;17:e0265996.
    PubMed    
    Abstract available

  382. D S P, Chaturvedi PK, Krishnamoorthy D, Seo YS, et al
    Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
    PLoS One. 2022;17:e0266532.
    PubMed    
    Abstract available

  383. YACOUTI A, Elkhoudri N, El Got A, Benider A, et al
    Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.
    PLoS One. 2022;17:e0266081.
    PubMed    
    Abstract available

  384. ROJAS ROJAS T, Poizot-Martin I, Rey D, Duvivier C, et al
    Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
    PLoS One. 2022;17:e0261069.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;